J. �stman

648 total citations
19 papers, 529 citations indexed

About

J. �stman is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, J. �stman has authored 19 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Genetics and 6 papers in Surgery. Recurrent topics in J. �stman's work include Diabetes and associated disorders (7 papers), Diabetes Management and Research (6 papers) and Pancreatic function and diabetes (6 papers). J. �stman is often cited by papers focused on Diabetes and associated disorders (7 papers), Diabetes Management and Research (6 papers) and Pancreatic function and diabetes (6 papers). J. �stman collaborates with scholars based in Sweden, Denmark and United States. J. �stman's co-authors include R Gunnarsson, Y Larsson, B. Scherst�n, Regina Wredling, Ulf Adamson, Christian Berne, L. Nystr�m, Bengt Littorin, Ann‐Kari Lefvert and A. Persson and has published in prestigious journals such as Diabetologia, Quality of Life Research and European Journal of Clinical Pharmacology.

In The Last Decade

J. �stman

19 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. �stman Sweden 13 293 203 199 83 74 19 529
Suzanne Strowig United States 15 462 1.6× 164 0.8× 105 0.5× 71 0.9× 136 1.8× 22 680
Richard A. Dickey United States 9 592 2.0× 182 0.9× 59 0.3× 87 1.0× 74 1.0× 29 826
P. M. S. Clark United Kingdom 5 348 1.2× 127 0.6× 78 0.4× 143 1.7× 161 2.2× 8 623
Norman R. Peden United Kingdom 7 276 0.9× 88 0.4× 121 0.6× 34 0.4× 36 0.5× 7 416
Neil Grey United States 11 394 1.3× 181 0.9× 80 0.4× 202 2.4× 117 1.6× 15 716
Sri Prakash Mokshagundam United States 13 288 1.0× 128 0.6× 71 0.4× 65 0.8× 135 1.8× 28 597
S Bunnag Thailand 10 91 0.3× 108 0.5× 47 0.2× 59 0.7× 44 0.6× 25 326
Janice Sepúlveda Reis Brazil 15 291 1.0× 153 0.8× 127 0.6× 58 0.7× 43 0.6× 46 529
Michael Koffler Israel 12 279 1.0× 124 0.6× 85 0.4× 177 2.1× 67 0.9× 26 627
L. Raymond Reynolds United States 11 235 0.8× 84 0.4× 42 0.2× 44 0.5× 103 1.4× 27 412

Countries citing papers authored by J. �stman

Since Specialization
Citations

This map shows the geographic impact of J. �stman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. �stman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. �stman more than expected).

Fields of papers citing papers by J. �stman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. �stman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. �stman. The network helps show where J. �stman may publish in the future.

Co-authorship network of co-authors of J. �stman

This figure shows the co-authorship network connecting the top 25 collaborators of J. �stman. A scholar is included among the top collaborators of J. �stman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. �stman. J. �stman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Landin‐Olsson, Mona, J. �stman, B. Scherst�n, et al.. (2000). Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds. Diabetes/Metabolism Research and Reviews. 16(6). 442–447. 50 indexed citations
2.
Wredling, Regina, et al.. (1995). Well-being and treatment satisfaction in adults with diabetes: A Swedish population-based study. Quality of Life Research. 4(6). 515–522. 97 indexed citations
3.
Nystr�m, L., H. J. Arnqvist, Folke Lithner, et al.. (1992). Male predominance of Type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15?34-year age group in Sweden. Diabetologia. 35(1). 56–62. 90 indexed citations
4.
Bolinder, Jan, et al.. (1991). Long-term metabolic control after pancreas transplantation with enteric exocrine diversion. Diabetologia. 34(S1). S76–S80. 10 indexed citations
6.
Johansson, Bo‐Lennart, et al.. (1991). Renal and splanchnic exchange of human biosynthetic C-peptide in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34(6). 423–428. 10 indexed citations
7.
Tibell, Annika, et al.. (1991). The Stockholm experience with pancreatic transplantation using enteric exocrine diversion. Diabetologia. 34(S1). S21–S23. 1 indexed citations
9.
Bergman, Ulf, et al.. (1980). Wide variation in serum chlorpropamide concentration in outpatients. European Journal of Clinical Pharmacology. 18(2). 165–169. 15 indexed citations
10.
Seideman, Peter, Leif Bertilsson, K. Haglund, et al.. (1980). Monoamine metabolites in cerebrospinal fluid during treatment of hypertension with prazosin. European Journal of Clinical Pharmacology. 18(5). 399–401. 4 indexed citations
11.
�stman, J., Peter Arner, C. G. Groth, et al.. (1980). Plasma C-peptide and serum insulin antibodies in diabetic patients receiving pancreatic transplants. Diabetologia. 19(1). 25–30. 11 indexed citations
12.
Bj�rntorp, P., et al.. (1978). Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus. Diabetologia. 15(2). 95–98. 13 indexed citations
13.
Bertilsson, Leif, K. Haglund, J. �stman, et al.. (1977). Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenolol. European Journal of Clinical Pharmacology. 11(2). 125–128. 23 indexed citations
14.
Collste, P., K. Haglund, Marianne Frisk‐Holmberg, et al.. (1976). Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. European Journal of Clinical Pharmacology. 10(2). 89–95. 22 indexed citations
15.
Arner, Peter & J. �stman. (1976). Abnormalities in the adrenergic control and the rate of lipolysis in isolated human subcutaneous adipose tissue in diabetes mellitus. Diabetologia. 12(6). 593–599. 18 indexed citations
16.
�stman, J., Lars Bäckman, & D Hallberg. (1975). Cell size and the antilipolytic effect of insulin in human subcutaneous adipose tissue. Diabetologia. 11(2). 159–164. 25 indexed citations
17.
Rawlins, M. D., et al.. (1974). Steady-state plasma concentrations of alprenolol in man. European Journal of Clinical Pharmacology. 7(5). 353–356. 21 indexed citations
18.
Carlson, Lars A., et al.. (1967). Suppression of splanchnic ketone body production in man by nicotinic acid. Diabetologia. 3(6). 494–499. 13 indexed citations
19.
Carlson, Lars A. & J. �stman. (1966). Plasma ?-hydroxybutyric acid response to nicotinic acid-induced plasma free fatty acid decrease in man. Diabetologia. 2(2). 127–129. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026